News

Professor Sally Barrington gives inaugural lecture

Sally Barrington

Professor Sally Barrington, Professor of PET Imaging here at the PET Centre, gave her inaugural lecture on the 1st March 2017. Professor Barrington is internationally known for her work in PET and lymphoma. During her lecture, she discussed how her work, based here at the PET Centre since it was opened in 1991, has led to more effective treatment with fewer side-effects for patients with cancer.

More information about the lecture can be found here.

New PET Suite at Guy's Cancer

Guy's Cancer opening

The PET Centre has expanded to a new PET Suite within the Cancer Centre at Guy's Hospital, where we have a new state-of-the-art PET-CT scanner. The Cancer Centre brings together most cancer imaging and treatment under one roof within a purpose-built building. The PET Suite welcomed its first patients in November 2016, and is now routinely scanning patients.

Secretary of State for Health Jeremy Hunt, who visited the Cancer Centre on the 9th February, praised the Trust for "leading the way in providing world class cancer care & treatment".

Professor Paul Marsden awarded inaugural John Mallard Award

Paul Marsden receives the John Mallard Award

Paul Marsden, Professor of PET Physics here at the PET Centre, has been awarded the inaugural John Mallard Award from the International Organisation for Medical Physics. Being presented for the first time, the award recognises Professor Marsden's work in developing a positron emission tomography (PET) detector system that functions properly and safely inside a MRI scanner. As a result of his pioneering work, whole body PET/MR systems were commercially available by 2010, and the second system in the UK was installed in our PET Centre in 2014.

More information about the award can be found on the IOMP Website.

First-in-man study with new radiotracer

BF4 First in man study

Here at the PET Centre we have recently performed the first-in-man study of a new radiotracer, [18F]tetrafluoroborate, which was developed here within the Division to investigate thyroid and head and neck cancer. The tracer, which is the world's first 18F labelled sodium/iodide symporter substrate and the first new tracer developed within the Division to reach clinical translation here, should improve detection of small metastases in thyroid and salivary cancer. A number of multidisciplinary teams including radiochemists, physicists, clinicians, imaging staff, nursing staff and researchers have worked together to make this complex study come to fruition.

Medibord launches a new Siemens Biograph mMR (PET-MRI) solution

Empty PET-MR scanner

In collaboration with our PET Centre, Medibord has developed a PET-MRI overlay which has been especially designed for a head and neck cancer research project within their PET Centre. The purpose of the research project is to establish a good quality PET-MR protocol for patients with head and neck cancer to be scanned in the radiotherapy treatment position, with the immobilization devices in situ.

For further information please contact Medibord, follow the link to the TOHETI website for the full article or contact us via our research pages.

Using PET scans to monitor treatment

PET Scans Monitor Treatment

Exciting new clinical trial results show that some patients with Hodgkin's Lymphoma could be spared damaging radiotherapy and still be free from their disease three years later. Academics including those from King's College London have published a study that offers patients better choices regarding treatment.

Read more about this article.